SOD isoforms, especially SOD2 and SOD1, have been shown in prior studies to have dual functions in glioma and glioblastoma by shielding tumor cells from oxidative stress and enhancing resistance to treatment. The gene discussed is SOD2; the disease is central nervous system cancer.